CUSIP: 72940R102
Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
545,974
-
Share change
-
+8,377
-
Total reported value
-
$1,922,708
-
Price per share
-
$3.52
-
Number of holders
-
19
-
Value change
-
+$29,000
-
Number of buys
-
1
Quarterly Holders Quick Answers
What is CUSIP 72940R102?
CUSIP 72940R102 identifies PSTI - PLURISTEM THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2014
-
Previous quarter:
Q3 2013
Recent filing periods for CUSIP 72940R102:
Institutional Holders of PLURISTEM THERAPEUTICS INC - COM (PSTI) as of Q4 2013
As of 31 Dec 2013,
PLURISTEM THERAPEUTICS INC - COM (PSTI) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
545,974 shares.
The largest 10 holders included
JPMORGAN CHASE & CO, Verity Asset Management, Inc., Tower Research Capital LLC, Psagot Investment House Ltd., OPPENHEIMER & CO INC, TWO SIGMA INVESTMENTS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, VAN ECK ASSOCIATES CORP, GROUP ONE TRADING, L.P., and Commonwealth Equity Services, Inc.
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.